← العودة إلى الصفحة الرئيسية
الولايات المتحدة · وكالات وأخبار لحظية · PR Newswire

FINN Partners releases new whitepaper highlighting challenges for scaling the UK and European biotech and biopharma industry

نشره PR Newswire · الولايات المتحدة منذ 24 د
FINN Partners releases new whitepaper highlighting challenges for scaling the UK and European biotech and biopharma industry
PR Newswire

ملخص مفصل

Whitepaper released as part of London Life Sciences Week explores what is needed to overcome the challenges facing biotech and biopharma in the UK and Europe. FINN Partners sets…

LONDON, Nov. 16, 2026 /PRNewswire/ -- Global independent marketing and communications firm FINN Partners has released a landmark whitepaper The Future of Biotech and Biopharma in the UK & Europe, published to coincide with London Life Sciences Week 2026.

The whitepaper analyses the structural barriers standing in the way of UK and continental European life science companies from becoming globally dominant market players.

Sophie Taylor-Roberts, managing partner and UK health lead, FINN Partners, said: "UK and European life sciences ecosystems generate world-class innovations, but as we know scientific excellence is not enough on its own to guarantee commercial success. To redress the balance, we need to eliminate the transatlantic scaling gap."

"As investors and life sciences leaders meet at London Life Sciences Week, our whitepaper examines the impact of cross-border manufacturing bottlenecks, addresses the realities of NHS and single-payer reimbursement, and provides a framework for what needs to be done to ensure the future success of the industry in the UK and Europe."

The whitepaper looks specifically at the problem of transatlantic capital deficiency and scaling, overcoming post-Brexit difficulties in manufacturing of the product due to CDMO logistics, and addressing health technology assessments (HTAs) in the UK and European single-payer markets. It also focusses on mitigating the risks related to health data security in the era of generative artificial intelligence and machine learning technologies.

How to surmount structural growth challenges: Though the "Golden Triangle" of the UK (Oxford, Cambridge, London) and research clusters in Europe including BioRN, Basel and Medicon Valley generate world-class scientific research, there are often difficulties with growth financing and lab space shortages. The whitepaper suggests creating a "connected density" across Europe to establish an efficient ecosystem of capital, talent and fluid infrastructure.

Fortifying supply…

P…

مطلع المقال، مقتطف من PR Newswire. لقراءة المقال كاملًا، افتحه على موقع الناشر.

اقرأ المقال كاملًا على PR Newswire سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.prnewswire.com)

يستحق القراءة أيضًا